Floreo was recently featured in Modern Healthcare in an article by Gabriel Perna. Thank you for sharing our news!
"When it comes to building and investing in digital health companies, Cleveland Clinic leaders say the
organization focuses on 'power alleys.'
Jon David 'JD' Friedland, director of ventures for the health system's innovation arm, dened 'power
alleys' as areas of clinical expertise. Cleveland Clinic Innovations has launched more than 100 startups
since its inception in 2000 and manages 23 portfolio companies centered on 'power alley' specialties,
including neurology, cardiovascular health, oncology and emerging areas of disruptor interest such as
autism care.
'Autism represents an obvious area where innovation is going to transform the eciency, the outcomes,
and some of the other challenges with respect to how care is delivered today,' Friedland said.
On April 2, Cleveland Clinic invested an undisclosed amount in startup Floreo, which has developed a
virtual reality software platform providing behavioral therapy for neurodiverse people, including those
with autism spectrum disorder. The investment gave Cleveland Clinic an equity stake and the right to
observe Floreo’s board.
As part of the deal, Floreo acquired Autism Eyes, an autism diagnostics and assessment company that
had been incubated and spun off by Cleveland Clinic Innovations."
